An AI tool accurately detected structural heart disease from smartwatch single-lead ECGs in a 600-person prospective trial.
Key Details
- 1AI model was trained using 266,000 12-lead ECGs from 110,000 patients and validated on large external cohorts.
- 2Prospective real-world testing was performed with 600 adults using smartwatch-recorded single-lead ECGs.
- 3Algorithm achieved 88% accuracy (AUC) in smartwatch data; sensitivity was 86% and negative predictive value 99%.
- 4Diseases detected included weakened pumping, valve damage, or thickened heart muscle—most commonly found with cardiac ultrasound (echo).
- 5Preliminary results were presented at AHA Scientific Sessions 2025 and have not yet been peer-reviewed.
Why It Matters
Wearable devices leveraging AI may democratize early detection of serious heart conditions, traditionally requiring advanced imaging. This signals a potential paradigm shift in accessible screening workflows, informing radiology and cardiology practice.
Source
EurekAlert
Related News
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.
•EurekAlert
AI-Enhanced CT Heart Fat Measurement Boosts Cardiovascular Risk Prediction
AI-derived measurement of heart fat from CT scans significantly improves long-term cardiovascular disease risk prediction.
•EurekAlert
Molecular Test BiliSeq Greatly Improves Bile Duct Cancer Detection
The BiliSeq molecular test developed at UPMC doubled detection sensitivity for bile duct cancer compared to standard pathology.